Toggle navigation
Logout
Change account settings
EN
DE
ES
FR
A-Z
Beta
About EconBiz
News
Thesaurus (STW)
Academic Skills
Help
EN
DE
ES
FR
My account
Logout
Change account settings
Login
Publications
Events
Your search terms
Search
Search options
All Fields
Title
Exact title
Subject
Author
Institution
ISBN/ISSN
Published in...
Publisher
Open Access only
Advanced
Search history
My EconBiz
Favorites
Loans
Reservations
Fines
You are here:
Home
Search: subject:"Partitioned survival model"
Narrow search
Narrow search
Year of publication
From:
To:
Subject
All
Partitioned survival model
4
Cost-efectiveness analysis
2
Cost-effectiveness
2
Cost-effectiveness analysis
2
Kosten-Wirksamkeits-Analyse
2
Non-small cell lung cancer
2
Sintilimab
2
Cancer
1
China
1
Chronic disease
1
Chronic lymphocytic leukemia
1
Chronische Krankheit
1
EVPI
1
Krebskrankheit
1
Markov chain
1
Markov model
1
Markov-Kette
1
Rituximab
1
Schweiz
1
Switzerland
1
Theorie
1
Theory
1
Venetoclax
1
more ...
less ...
Online availability
All
Free
3
CC license
1
Undetermined
1
Type of publication
All
Article
4
Type of publication (narrower categories)
All
Article in journal
3
Aufsatz in Zeitschrift
3
Article
1
Language
All
English
4
Author
All
He, Qi
2
Liu, Huiqin
2
Wang, Ying
2
Armoiry, Xavier
1
Auguste, Peter
1
Barbier, Michaela
1
Bennison, Craig
1
Connock, Martin
1
Durno, Nicholas
1
Knapp, Christian
1
Schwenkglenks, Matthias
1
Örtli, Mathias
1
more ...
less ...
Published in...
All
The European journal of health economics
2
Health Economics Review
1
Health economics review
1
Source
All
ECONIS (ZBW)
3
EconStor
1
Showing
1
-
4
of
4
Sort
relevance
articles prioritized
date (newest first)
date (oldest first)
1
Cost-effectiveness analysis of sintilimab plus pemetrexed and platinum versus chemotherapy alone as first-line treatment in metastatic non-squamous non-small cell lung cancer in China
Liu, Huiqin
;
Wang, Ying
;
He, Qi
- In:
Health Economics Review
12
(
2022
)
1
,
pp. 1-10
perspective of the Chinese healthcare system using a
partitioned
survival
model
with three mutually exclusive health states …
Persistent link: https://www.econbiz.de/10014489926
Saved in:
2
Cost-effectiveness analysis of sintilimab plus pemetrexed and platinum versus chemotherapy alone as first-line treatment in metastatic non-squamous non-small cell lung cancer in China
Liu, Huiqin
;
Wang, Ying
;
He, Qi
- In:
Health economics review
12
(
2022
)
1
,
pp. 1-10
perspective of the Chinese healthcare system using a
partitioned
survival
model
with three mutually exclusive health states …
Persistent link: https://www.econbiz.de/10013492965
Saved in:
3
Cost-effectiveness and budget impact of venetoclax in combination with rituximab in relapsed/refractory chronic lymphocytic leukemia in Switzerland
Barbier, Michaela
;
Durno, Nicholas
;
Bennison, Craig
; …
- In:
The European journal of health economics
23
(
2022
)
5
,
pp. 837-846
Persistent link: https://www.econbiz.de/10013279318
Saved in:
4
A comparison of published time invariant Markov models with Partitioned Survival models for cost effectiveness estimation : three case studies of treatments for glioblastoma multiforme
Connock, Martin
;
Auguste, Peter
;
Armoiry, Xavier
- In:
The European journal of health economics
22
(
2021
)
1
,
pp. 89-100
Persistent link: https://www.econbiz.de/10012433955
Saved in:
Results per page
10
25
50
100
250
A service of the
zbw
×
Loading...
